Finance Home - My Yahoo - Yahoo! - Help

Monday, December 7, 2009, 2:47AM ET - U.S. Markets open in 6 hours and 43 minutes. Dow  0.22% Nasdaq  0.00%

Questcor Pharmaceuticals, Inc. (QCOR)

On Dec 4: 4.51   0.06 (1.35%)

MORE ON QCOR

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Competitors Get Competitors for:
DIRECT COMPETITOR COMPARISON   QCOR Pvt1 NVS SNY Industry Market Cap: 289.38M N/A 126.17B 102.83B 98.96M Employ­ees: 46 3001 99,000 98,213 68 Qtrly Rev Growth (yoy): -42.80% N/A 2.40% 8.50% 19.70% Revenue (ttm): 89.43M 25.00M1 42.31B N/A 14.01M Gross Margin (ttm): 92.20% N/A 72.61% 75.20% 65.67% EBITDA (ttm): 45.77M N/A 11.24B N/A -12.30M Oper Margins (ttm): 50.64% N/A 21.50% N/A -137.11% Net Income (ttm): 34.45M N/A 7.59B N/A N/A EPS (ttm): 0.513 N/A 3.34 N/A -0.33 P/E (ttm): 8.79 N/A 16.63 N/A 17.26 PEG (5 yr expected): 0.51 N/A 2.88 2.61 1.28 P/S (ttm): 3.19 N/A 2.99 N/A 9.45 Pvt1 = Lundbeck Inc. (privately held) NVS = Novartis AG SNY = Sanofi-Aventis Industry = Biotechnology 1 = As of 2008   BIOTECHNOLOGY COMPANIES RANKED BY SALES   Company Symbol Price Change Market Cap P/E Amgen Inc. AMGN 56.85 0.53% 57.54B 12.40 Genentech, Inc. Private - View Profile Biogen Idec Inc. BIIB 48.18 1.69% 13.93B 16.12 Genzyme Corp. GENZ 49.98 -0.58% 13.26B 28.49 Merck Serono S.A. Private - View Profile Chiron Corporation Private - View Profile Gilead Sciences Inc. GILD 46.59 0.71% 41.93B 18.02 MedImmune, Inc. Private - View Profile Life Technologies Corporation LIFE 50.64 0.78% 9.03B 1033.47 Teva Pharmaceutical Industries Limited TEVA 54.01 0.82% 47.58B 49.41 View Biotechnology Industry Center GENERIC DRUGMAKERS RANKED BY SALES   Company Symbol Price Change Market Cap P/E Sandoz International GmbH Private - View Profile Watson Pharmaceuticals Inc. WPI 37.90 1.64% 4.02B 19.54 King Pharmaceuticals Inc. KG 11.72 0.43% 2.91B N/A Ranbaxy Laboratories Limited Private - View Profile Mylan, Inc. MYL 17.99 -1.15% 5.50B 110.37 Pfizer Inc. PFE 18.49 -0.80% 149.21B 15.36 Johnson & Johnson JNJ 64.36 0.31% 177.58B 14.06 GlaxoSmithKline plc GSK 42.75 0.73% 108.37B 13.49 Sanofi-Aventis SNY 39.38 -0.35% 102.83B N/A Novartis AG NVS 55.55 -0.41% 126.17B 16.63 View Biotechnology Industry Center DRUGMAKERS RANKED BY SALES   Company Symbol Price Change Market Cap P/E RHHBY.PK 41.42 -1.03% N/A N/A AstraZeneca plc AZN 46.30 1.49% 67.13B 9.30 Abbott Laboratories ABT 53.78 -0.85% 83.18B 14.57 Bristol-Myers Squibb Co. BMY 25.14 -0.08% 49.80B 13.01 View Biotechnology Industry Center NEWS ON DIRECT COMPETITORS   • NVS Astra-Zeneca Flies to JUPITER on Drug Results Sun 9:04am - at Seeking Alpha • NVS Novartis Could Be the Biggest Loser in Alcon Deal with Nestle Sun 7:50am - at Seeking Alpha • NVS Baxter Receives H1N1 Vaccine Order Fri, Dec 4 - Zacks.com • SNY Lilly's Effient Proves Its Worth Fri, Dec 4 - Zacks.com • SNY Good News for CytRx Fri, Dec 4 - Zacks.com • NVS Bayer Advances on Alzheimer's Plan Fri, Dec 4 - Zacks.com • SNY REO Speedwagon, The Game Thu, Dec 3 - at Forbes.com • SNY Sanofi's Multaq Gains EU Approval Thu, Dec 3 - Zacks.com • SNY Behind the Business: 3 Questions for Vical Thu, Dec 3 - at Motley Fool • SNY Don't Doubt The Comcast Deal Thu, Dec 3 - at Forbes.com • NVS Novartis cleared by EC for a COPD treatment Thu, Dec 3 - at MarketWatch • SNY Tough Sell: Sanofi Hands Out 750 Pink Slips to Sales Force Wed, Dec 2 - at The Wall Street Journal Online • NVS Tired of Waiting, Teva Advances Wed, Dec 2 - at Motley Fool • NVS Stem Cell Stocks Explode Higher on NIH Announcement Wed, Dec 2 - Indie Research • NVS H1N1: What It Means for Pharma Wed, Dec 2 - at Seeking Alpha • SNY Immunogen's Busy Month, Part II Wed, Dec 2 - at Seeking Alpha • SNY The Man Who Will Run NBC Wed, Dec 2 - at Forbes.com • NVS UBS ups Europe pharma rating to overweight Wed, Dec 2 - at MarketWatch • NVS 5-Star Stocks on the Upswing Tue, Dec 1 - at Motley Fool All Headlines for these symbols... Need more? Get unbiased, in-depth information on public and private companies worldwide from Hoover's Online.
Add to Portfolio     Set Alert     Email to a Friend Get Competitors for Another Symbol: Symbol Lookup • Stock Screener • Sector Analysis